These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 7805982)

  • 1. Evaluation of transvaginal color Doppler sonography, transvaginal sonography and CA 125 for prediction of ovarian malignancy.
    Sengoku K; Satoh T; Saitoh S; Abe M; Ishikawa M
    Int J Gynaecol Obstet; 1994 Jul; 46(1):39-43. PubMed ID: 7805982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood flow characteristics of ovarian tumors: implications for ovarian cancer screening.
    Carter JR; Lau M; Fowler JM; Carlson JW; Carson LF; Twiggs LB
    Am J Obstet Gynecol; 1995 Mar; 172(3):901-7. PubMed ID: 7892883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic examination, transvaginal ultrasound and transvaginal color Doppler sonography as predictors of ovarian cancer.
    Buckshee K; Temsu I; Bhatla N; Deka D
    Int J Gynaecol Obstet; 1998 Apr; 61(1):51-7. PubMed ID: 9622173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative detection of ovarian cancer by color Doppler ultrasonography and CA 125.
    Hossain F; Karim MN; Rahman SM; Khan N; Siddiqui M; Hussain R
    Bangladesh Med Res Counc Bull; 2010 Aug; 36(2):68-73. PubMed ID: 21473205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical evaluation of transvaginal Doppler studies, transvaginal sonography, magnetic resonance imaging, and CA 125 in detecting ovarian cancer.
    Hata K; Hata T; Manabe A; Sugimura K; Kitao M
    Obstet Gynecol; 1992 Dec; 80(6):922-6. PubMed ID: 1448260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Color Doppler ultrasonography and serum CA 125 in the differentiation of benign and malignant ovarian tumors.
    Chou CY; Chang CH; Yao BL; Kuo HC
    J Clin Ultrasound; 1994 Oct; 22(8):491-6. PubMed ID: 7814654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transvaginal color Doppler and CA125 as tools in the differential diagnosis of postmenopausal ovarian masses.
    Botsis D; Kassanos D; Kalogirou D; Karakitsos P; Liapis A; Antoniou G
    Maturitas; 1997 Apr; 26(3):203-9. PubMed ID: 9147352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative assessment of ovarian tumors by CA 125 measurement and transvaginal color Doppler ultrasound.
    Kupesić S; Vujisić S; Kurjak A; Mihaljević D; Radosević S
    Acta Med Croatica; 2002; 56(1):3-10. PubMed ID: 12455447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Diagnostic Value of Transvaginal Sonograph (TVS), Color Doppler, and Serum Tumor Marker CA125, CEA, and AFP in Ovarian Cancer.
    Zhang F; Zhang ZL
    Cell Biochem Biophys; 2015 Jun; 72(2):353-7. PubMed ID: 25582421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow Doppler.
    Carter J; Saltzman A; Hartenbach E; Fowler J; Carson L; Twiggs LB
    Obstet Gynecol; 1994 Jan; 83(1):125-30. PubMed ID: 8272293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits and limitations of ultrasonographic evaluation of uterine adnexal lesions in early detection of ovarian cancer.
    Varras M
    Clin Exp Obstet Gynecol; 2004; 31(2):85-98. PubMed ID: 15266758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of clinical evaluation for the level of CA-125 antigen and ultrasonographic color Doppler examination in diagnosis of ovarian tumor].
    Czekierdowski A; Zrubek H; Sikorski M; Wiktor H; Józefczak M; Stachowicz N
    Ginekol Pol; 1996 Nov; 67(11):552-6. PubMed ID: 9289441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses.
    Antonić J; Rakar S
    Anticancer Res; 1995; 15(4):1527-32. PubMed ID: 7654041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Color Doppler ultrasound in the preoperative assessment of adnexal masses.
    Zanetta G; Vergani P; Lissoni A
    Acta Obstet Gynecol Scand; 1994 Sep; 73(8):637-41. PubMed ID: 7941989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The estimation of the probability of tumor malignacy on the basis of test combination in the primary diagnosis of adnexal tumors].
    Smoleń A; Stachowicz N; Czekierowski A; Kotarski J
    Ginekol Pol; 2010 Apr; 81(4):254-61. PubMed ID: 20476596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Color Doppler ultrasonography for prediction of malignant ovarian tumors.
    Benjapibal M; Sunsaneevitayakul P; Boriboonhirunsarn D; Sutanthavibul A; Chakorngowit M
    J Med Assoc Thai; 2002 Jun; 85(6):709-15. PubMed ID: 12322845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of pelvic masses with transabdominal color Doppler, CA 125 and ultrasonography.
    Franchi M; Beretta P; Ghezzi F; Zanaboni F; Goddi A; Salvatore S
    Acta Obstet Gynecol Scand; 1995 Oct; 74(9):734-9. PubMed ID: 7572110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transvaginal color Doppler ultrasonography and CA-125 in suspicious adnexal masses.
    Alcázar JL; Errasti T; Zornoza A; Mínguez JA; Galán MJ
    Int J Gynaecol Obstet; 1999 Sep; 66(3):255-61. PubMed ID: 10580673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doppler flow and arterial location in ovarian tumors.
    Itakura T; Kikkawa F; Kajiyama H; Mitsui T; Kawai M; Mizutani S
    Int J Gynaecol Obstet; 2003 Dec; 83(3):277-83. PubMed ID: 14643038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.